Can we predict the benefit of CDK4/6 inhibitor treatment using the ratios of neutrophils, monocytes and platelets to lymphocytes in peripheral blood of metastatic breast cancer patients?
Moukas, S.I. ; Kasimir-Bauer, S. ; Tewes, M. ; Kolberg, H.-C. ; Kimmig, R. ; Keup, C.
Senologie - Zeitschrift für Mammadiagnostik und -therapie, 2022, Vol.19 (2)Rüdigerstraße 14, 70469 Stuttgart, Germany: Georg Thieme Verlag
Texto completo disponível